These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5655572)

  • 41. [Pepper type neuroblastoma with homocystinuria. Diagnosis, biochemistry and therapy].
    Mönch E; Stefan H; Käser H
    Helv Paediatr Acta; 1970 Nov; 25(5):530-41. PubMed ID: 5493570
    [No Abstract]   [Full Text] [Related]  

  • 42. Vincristine and cyclophosphamide therapy in generalized neuroblastoma. A collaborative study.
    Am J Dis Child; 1970 Apr; 119(4):308-13. PubMed ID: 5434587
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ophthalmological aspects of neuroblastomatosis: a study of 53 verified cases.
    Alfano JE
    Trans Am Acad Ophthalmol Otolaryngol; 1968; 72(6):830-48. PubMed ID: 4302354
    [No Abstract]   [Full Text] [Related]  

  • 45. Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma.
    Clarke E; Glaser AW; Picton SV
    Pediatr Hematol Oncol; 2003 Sep; 20(6):467-71. PubMed ID: 14631621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroblastoma. A study of 144 cases treated in the Institut Gustave-Roussy over a period of 7 years.
    Stella JG; Schweisguth O; Schlienger M
    Am J Roentgenol Radium Ther Nucl Med; 1970 Feb; 108(2):325-32. PubMed ID: 5412867
    [No Abstract]   [Full Text] [Related]  

  • 47. Carboplatin activity in cisplatin treated neuroblastoma.
    Lewis IJ; Stevens MC; Pearson AD; Pinkerton CR; Barnes JM
    Prog Clin Biol Res; 1991; 366():553-9. PubMed ID: 2068173
    [No Abstract]   [Full Text] [Related]  

  • 48. Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
    Bomken S; Davies B; Chong L; Cole M; Wood KM; McDermott M; Tweddle DA
    Pediatr Hematol Oncol; 2011 Mar; 28(2):106-14. PubMed ID: 21214410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroblastoma: therapy for infants with good prognosis.
    Nitschke R; Humphrey GB; Sexauer CL; Smith EI
    Med Pediatr Oncol; 1983; 11(3):154-8. PubMed ID: 6855697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neuroblastoma study NBL 79 of the German Society for Pediatric Oncology. Report after 2 years].
    Berthold F; Treuner J; Brandeis WE; Evers G; Haas RJ; Harms D; Jürgens H; Kaatsch P; Michaelis J; Niethammer D; Prindull G; Riehm H; Winkler K; Lampert F
    Klin Padiatr; 1982; 194(4):262-9. PubMed ID: 6182343
    [No Abstract]   [Full Text] [Related]  

  • 52. [Combined chemotherapy of neuroblastoma. 1st results in 40 children with metastatic form].
    Zucker JM; Mercier JC
    Arch Fr Pediatr; 1976; 33(6):555-67. PubMed ID: 949221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma.
    Kushner BH; Kramer K; Modak S; Yataghene K; Cheung NK
    Eur J Cancer; 2011 Jan; 47(1):84-9. PubMed ID: 20934323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug trials in neuroblastoma: cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus cyclophosphamide; 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone.
    Starling KA; Sutow WW; Donaldson MH; Land VJ; Lane DM
    Cancer Chemother Rep; 1974; 58(5 Pt 1):683-8. PubMed ID: 4426047
    [No Abstract]   [Full Text] [Related]  

  • 55. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
    Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sympathoma in children. Notes on 5 clinical cases].
    Burdea M; Brătianu A; Tansanu I; Răutu I; Mănăilă V
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(4):773-8. PubMed ID: 4453712
    [No Abstract]   [Full Text] [Related]  

  • 58. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
    Shafford EA; Rogers DW; Pritchard J
    J Clin Oncol; 1984 Jul; 2(7):742-7. PubMed ID: 6539811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of neuroblastoma.
    Evans AE
    Cancer; 1972 Dec; 30(6):1595-9. PubMed ID: 4641765
    [No Abstract]   [Full Text] [Related]  

  • 60. Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.
    Kushner BH; O'Reilly RJ; LaQuaglia M; Cheung NK
    Cancer; 1990 Sep; 66(6):1095-100. PubMed ID: 2400963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.